Skip to main content

Table 1 Sensitivity analysis of the costs for PUFAs administration

From: Equity, acceptability and feasibility of using polyunsaturated fatty acids in children and adolescents with autism spectrum disorder: a rapid systematic review

 Estimated costs for a therapeutic cycle (€)
Lower scenarioBase case scenarioUpper scenario
Short therapeutic cycle (6 weeks)5,532,853,7
Intermediate therapeutic cycle (12 weeks)10,965,5107,4
Long therapeutic cycle (52 weeks)47,5284,7466,5